Funding

This funding information is current as of 2025.

The ENA has received funding from the European Union’s Horizon 2020 and Horizon Europe research and innovation programme under grant agreement numbers AtlantECO [862923], AQUARIUS [101130915], BGE [101059492], BioOcean5D [101059915], Blue-Cloud 2026 [101094227], Contagio [101137283], eDNAqua-Plan [101112800], EVORA [101131959], MICROBE [10194353], and VEO [874735].

The work of ENA was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) Metagenomics Portal IV [grant number BB/V01868X/1], in part by the Wellcome Trust [Darwin Tree of Life 226458/Z/22/Z]. Funding from the Gordon and Betty Moore Foundation through Aquatic Symbiosis [MOORE-8897]. The ENA was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number U24AI183840 (Pathogen Data Network). The project was also supported by the Novo Nordisk Foundation and Wellcome via the AEGIS grant [NNF24SA0092560].

Funding was also provided for the ENA from the European Molecular Biology Laboratory.